Lymphoid Malignancies

<p><strong>Chronic Myeloid Leukemia</strong> (CML) remains a key model for the improved understanding of the pathophysiology of a malignancy at a molecular level and has been used by researchers to develop a variety of therapies and therapeutic assessment methods. This concise, readable guide assembles and synthesizes the latest developments and tr

Gorczyca, Wojciech

Cerroni, Lorenzo

<p>Written by authors from the world's most prominent cancer centers, <strong><em>Chronic Lymphocytic Leukemia</em></strong> supplies a comprehensive, up-to-date picture of CLL and how to better treat patients inflicted with the disease.</p><p>New information on developments in the molecular pathogenesis of this disease impacts how physicians approach and treat patients with CLL. The various predisposing factors for the disease are addressed along with current and future treatment modalities and recommended standards of care.</p><p>Key features include: </p><ul> <ul> </ul> <li>introduction by Kanti Rai, MD who developed the Rai Classification and Staging system used in CLL diagnosis</li> <li>CLL in relationship to gene expression profiling and molecular abnormalities</li> <li>familial clustering and gene predisposition</li> <li>targeted therapy trials</li> <li>clinical patient management based upon stage and progression of disease</li> </ul>

Raza, Azra

Available